WO2001079238A3 - Haplotypes du gene mmp3 - Google Patents

Haplotypes du gene mmp3 Download PDF

Info

Publication number
WO2001079238A3
WO2001079238A3 PCT/US2001/012452 US0112452W WO0179238A3 WO 2001079238 A3 WO2001079238 A3 WO 2001079238A3 US 0112452 W US0112452 W US 0112452W WO 0179238 A3 WO0179238 A3 WO 0179238A3
Authority
WO
WIPO (PCT)
Prior art keywords
mmp3
gene
haplotypes
disclosed
mmp3 gene
Prior art date
Application number
PCT/US2001/012452
Other languages
English (en)
Other versions
WO2001079238A2 (fr
Inventor
Steven C Bentivegna
Anne Chew
Julie Y Choi
Beena Koshy
J Claiborne Stephens
Original Assignee
Genaissance Pharmaceuticals
Steven C Bentivegna
Anne Chew
Julie Y Choi
Beena Koshy
J Claiborne Stephens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Steven C Bentivegna, Anne Chew, Julie Y Choi, Beena Koshy, J Claiborne Stephens filed Critical Genaissance Pharmaceuticals
Priority to AU2001257073A priority Critical patent/AU2001257073A1/en
Publication of WO2001079238A2 publication Critical patent/WO2001079238A2/fr
Publication of WO2001079238A3 publication Critical patent/WO2001079238A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des polymorphismes mononucléotidiques présents dans le gène humain de la métalloprotéinase matricielle 3 (MMP3). Par ailleurs, elle se rapporte à différents génotypes, haplotypes et paires d'haplotypes pour le gène MMP3 qui existent dans la population. L'invention concerne également des compositions et des méthodes destinées à soumettre le gène MMP3 à un haplotypage et/ou un génotypage chez un individu. Elle porte enfin sur des polynucléotides contenant l'un au moins des polymorphismes MMP3 susmentionnés.
PCT/US2001/012452 2000-04-17 2001-04-17 Haplotypes du gene mmp3 WO2001079238A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001257073A AU2001257073A1 (en) 2000-04-17 2001-04-17 Haplotypes of the mmp3 gene

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19791100P 2000-04-17 2000-04-17
US60/197,911 2000-04-17
US21809200P 2000-07-13 2000-07-13
US60/218,092 2000-07-13

Publications (2)

Publication Number Publication Date
WO2001079238A2 WO2001079238A2 (fr) 2001-10-25
WO2001079238A3 true WO2001079238A3 (fr) 2002-05-30

Family

ID=26893270

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/012452 WO2001079238A2 (fr) 2000-04-17 2001-04-17 Haplotypes du gene mmp3

Country Status (2)

Country Link
AU (1) AU2001257073A1 (fr)
WO (1) WO2001079238A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2459098A (en) * 2008-04-08 2009-10-14 Ethicon Inc Genetic markers of wound development

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SAUS J. ET AL.: "The complete primary structure of human matrix metalloproteinase-3", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 263, no. 14, May 1998 (1998-05-01), pages 6742 - 6745, XP002935027 *

Also Published As

Publication number Publication date
AU2001257073A1 (en) 2001-10-30
WO2001079238A2 (fr) 2001-10-25

Similar Documents

Publication Publication Date Title
WO2001079229A3 (fr) Haplotypes du gene cxcr4
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2002006294A3 (fr) Haplotypes du gene mmp13
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2001077124A3 (fr) Haplotypes du gene apoa4
WO2001090123A3 (fr) Haplotypes du gene agtrl1
WO2001079228A3 (fr) Haplotypes du gene f12
WO2001079238A3 (fr) Haplotypes du gene mmp3
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2001079240A3 (fr) Haplotypes du gene rangap1
WO2001079218A3 (fr) Haplotypes du gene calm1
WO2001079223A3 (fr) Haplotypes du gene akr1b1
WO2001077129A3 (fr) Haplotypes du gene apoc1
WO2001077131A3 (fr) Haplotypes du gene bglap
WO2001079219A3 (fr) Haplotypes du gene ache
WO2001072965A3 (fr) Haplotypes du gene fkbp8
WO2001079237A3 (fr) Haplotypes du gene galr1
WO2001077132A3 (fr) Haplotypes du gene il5
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2001077128A3 (fr) Haplotypes du gene slc5a3
WO2001079221A3 (fr) Haplotypes du gene il8rb
WO2001075063A3 (fr) Haplotypes du gene chrnb3
WO2001083499A3 (fr) Haplotypes du gene de l'il8
WO2001072966A3 (fr) Haplotypes du gene pltp

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP